v3.10.0.1

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
STATEMENTS OF OPERATIONS - USD ($)	May 31, 2018	May 31, 2017
Revenues	$ 0	$ 0
Operating Expenses
Research and development	2,279,825	2,383,769
Administrative	1,495,415	754,317
Professional fees	648,379	867,084
Depreciation and amortization	1,020	1,020
Operating loss	(4,424,639)	(4,006,190)
Other income (expense)
Interest income	3	3
Interest expense	(611,547)	(557,534)
Loss before income taxes	(5,036,183)	(4,563,721)
Provision for income taxes	0	0
Net loss	$ (5,036,183)	$ (4,563,721)
Weighted average number of common shares outstanding – basic and diluted	33,546,852	28,767,582
Loss per common share – basic and diluted	$ (0.15)	$ (0.16)

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

PROTALEX INC 10-K